Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-459-7 | CAS number: 107-07-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study meets scientific standards with acceptable restrictions (dose-range-finding study; exposure period only 14 days; limited toxicological parameters studied, e.g. no haematology, clinical chemistry, histopathology; reliable concerning body weight and mortality)
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicology and carcinogenesis studies of 2-chloroethanol (ethylene chlorohydrin) in F344/N Rats and Swiss CD-1 Mice (dermal studies)
- Author:
- NTP
- Year:
- 1 985
- Bibliographic source:
- NTP TR 275; National Institutes of Health (USA), NIH Publication No.86-2531
Materials and methods
- Principles of method if other than guideline:
- Dose-range-finding study; toxic effects in a subacute dermal study in rats
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- 2-chloroethanol
- EC Number:
- 203-459-7
- EC Name:
- 2-chloroethanol
- Cas Number:
- 107-07-3
- Molecular formula:
- C2H5ClO
- IUPAC Name:
- 2-chloroethan-1-ol
- Details on test material:
- Kodak Co. (lot no. A3X)
identified by infrared spectroscopy and nuclear magnetic resonance spectroscopy
purity >99%
stored in the dark at 5 C; no degradation (analysis)
solution in water stable for more than 21 days
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: F344/N
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Source: Charles River Breeding Laboratories (Portage, Ml; USA)
- Acclimatisation: 4 weeks
- Age at study initiation: 8 wk
- mean weight at study initiation: males 173-181 g; females 128-137 g
- Fasting period before study: no data
- Housing: rats housed 5 per cage
- Diet (Purina Lab Chow) ad libitum
- Water (Tap water acidified to pH 2.5 by HCl) ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-25
- Humidity (%): 30-70
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- other: ethanol/water, 80/20
- Details on exposure:
- Route of Administration: dermal
TEST SITE
- Area of exposure: interscapular region, hair clipped (6 cm x 6 cm);
- clipplings 2 times per week
- Application volume: 0.1 ml - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 14 days
- Frequency of treatment:
- once daily
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 20, 30, 40, 60, 80 mg/rat
Basis:
other: nominal per rat
- Remarks:
- Doses / Concentrations:
0/0, 114/147, 172/222, 226/313, 339/451, 442/611 mg/kg bw (males/females)
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Post-exposure period: no
- Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- clinical signs recorded 2-times per day
Body weight measured at day 0, 7, and 14 - Sacrifice and pathology:
- Necropsy performed
- Other examinations:
- no
- Statistics:
- no data
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Dermal irritation:
- not specified
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- Mortality: 2/5 females at 60 mg/rat (but all other female rats including high dose females survived) and 1/5 males at 80 mg/rat.
Body weight gain: no effects detectable.
No data given on clinical signs or necropsy in the result section.
Effect levels
- Dose descriptor:
- NOEL
- Effect level:
- 40 other: mg/rat
- Sex:
- male/female
- Basis for effect level:
- other: related to mortality and bdy weight
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Dose-range-finding study for the subsequent 13 -week study.
Applicant's summary and conclusion
- Conclusions:
- In rats dermal exposure to doses up to 40 mg/rat once daily (226/313 mg/kg bw/day in males/females) for 14 days has no effects on body weight or survival.
- Executive summary:
The study meets scientific standards with acceptable restrictions (dose-range-finding study; exposure period only 14 days; limited toxicological parameters studied, e.g. no haematology, clinical chemistry, histopathology; reliable concerning body weight and mortality).
Five male and 5 female F344/N rats were dermally exposed once daily to 0, 20, 30, 40, 60, 80 mg/rat (corresponding to 0/0, 114/147, 172/222, 226/313, 339/451, 442/611 mg/kg bw in males/females) for 14 days. Mortality occurred in 2/5 females at 60 mg/rat (but all other female rats including high dose females survived) and 1/5 males at 80 mg/rat. No effects were reported on body weight gain.
Conclusion: In rats dermal exposure to doses up to 40 mg/rat once daily (226/313 mg/kg bw/day in males/females) for 14 days has no effects on body weight or survival.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
